Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
170 |
|
| Actual shortage: | 6 (4%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 5 (3%) | |
| Resolved: | 158 (93%) | |
Discontinuation Reports |
54 |
|
| To be discontinued: | 2 (4%) | |
| Discontinued: | 52 (96%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (15%) |
|
Overdue reports |
5 (56%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-04-11 | 2022-06-17 | 158484 |
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-10-25 | 2023-01-25 | 172560 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-03-26 | 2018-04-13 | 44006 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-04-27 | 2018-05-25 | 47334 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-21 | 54449 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2019-03-21 | 2019-04-18 | 79161 |
| PATADAY | 0.2% | SOLUTION | Resolved | 2019-05-07 | 2019-06-19 | 83364 |
| PATANOL | 0.1% | LIQUID | Resolved | 2018-06-01 | 2018-06-19 | 51067 |
| PAZEO | 0.7% | SOLUTION | Resolved | 2020-01-20 | 2020-03-31 | 103745 |
| PAZEO | 0.7% | SOLUTION | Resolved | 2020-05-05 | 2020-05-21 | 114100 |
| RITALIN 20MG | 20MG | TABLET | Resolved | 2017-06-07 | 2017-08-31 | 12261 |
| RITALIN-SR TAB 20MG | 20MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-25 | 2017-06-02 | 11280 |
| SANDOSTATIN | 50MCG | SOLUTION | Resolved | 2022-11-22 | 2023-02-11 | 175439 |
| SANDOSTATIN | 50MCG | SOLUTION | Actual shortage | 2024-03-22 | 2024-10-01 | 223074 |
| SANDOSTATIN | 100MCG | SOLUTION | Resolved | 2022-05-06 | 2023-02-11 | 160174 |
| SANDOSTATIN | 100MCG | SOLUTION | Actual shortage | 2024-02-06 | 2024-03-21 | 218624 |
| SANDOSTATIN LAR | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE | Actual shortage | 2025-04-03 | 2025-04-15 | 254019 |
| SANDOSTATIN LAR | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE | Actual shortage | 2025-04-03 | 2025-04-09 | 254013 |
| SIMULECT | 20MG | POWDER FOR SOLUTION | Resolved | 2024-07-10 | 2024-09-10 | 232638 |
| TEGRETOL | 200MG | TABLET | Resolved | 2024-08-27 | 2024-10-30 | 235974 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEGRETOL CHEWTABS 200 MG | 200MG | TABLET | Discontinued | 2017-05-01 | 2017-06-06 | 8500 |
| TRANSDERM-NITRO 0.2 | 0.2MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119960 |
| TRANSDERM-NITRO 0.4 | 0.4MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119964 |
| TRANSDERM-NITRO 0.6 | 0.6MG | PATCH (EXTENDED RELEASE) | Discontinued | 2021-05-05 | 2022-01-17 | 138767 |
| VOLTAREN | 50MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-01-08 | 2020-03-10 | 102699 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Discontinued | 2019-09-11 | 2019-11-07 | 93561 |
| VOLTAREN SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-07-10 | 2019-09-06 | 89039 |
| VOLTAREN SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-04-02 | 2019-09-11 | 80298 |
| VOLTAREN | 100MG | SUPPOSITORY | Discontinued | 2017-05-01 | 2017-11-02 | 8504 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-09-23 | 123900 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-05-05 | 123894 |